222 related articles for article (PubMed ID: 1990959)
41. Tenascin-C is highly expressed in respiratory distress syndrome and bronchopulmonary dysplasia.
Kaarteenaho-Wiik R; Kinnula VL; Herva R; Soini Y; Pöllänen R; Pääkkö P
J Histochem Cytochem; 2002 Mar; 50(3):423-31. PubMed ID: 11850444
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronchopulmonary dysplasia.
Bry K; Hogmalm A; Bäckström E
Semin Perinatol; 2010 Jun; 34(3):211-21. PubMed ID: 20494738
[TBL] [Abstract][Full Text] [Related]
43. Normal pulmonary gas exchange efficiency and absence of exercise-induced arterial hypoxemia in adults with bronchopulmonary dysplasia.
Lovering AT; Laurie SS; Elliott JE; Beasley KM; Yang X; Gust CE; Mangum TS; Goodman RD; Hawn JA; Gladstone IM
J Appl Physiol (1985); 2013 Oct; 115(7):1050-6. PubMed ID: 23869070
[TBL] [Abstract][Full Text] [Related]
44. Bronchopulmonary dysplasia patients have preserved CT-measured central airway luminal area.
Guo WL; Eli IM; Ripoll JG; Baker SE; Shepherd JRA; Wiggins CC; Welch BT; Joyner MJ; Dominelli PB
Respir Med; 2020; 170():106071. PubMed ID: 32843156
[TBL] [Abstract][Full Text] [Related]
45. NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/ 64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Oct; 440():1-314. PubMed ID: 12595923
[TBL] [Abstract][Full Text] [Related]
46. Chronic lung injury in preterm lambs. Disordered respiratory tract development.
Albertine KH; Jones GP; Starcher BC; Bohnsack JF; Davis PL; Cho SC; Carlton DP; Bland RD
Am J Respir Crit Care Med; 1999 Mar; 159(3):945-58. PubMed ID: 10051278
[TBL] [Abstract][Full Text] [Related]
47. The effect of bronchopulmonary dysplasia on growth at school age.
Vrlenich LA; Bozynski ME; Shyr Y; Schork MA; Roloff DW; McCormick MC
Pediatrics; 1995 Jun; 95(6):855-9. PubMed ID: 7761209
[TBL] [Abstract][Full Text] [Related]
48. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation.
Baraldi E; Bonetto G; Zacchello F; Filippone M
Am J Respir Crit Care Med; 2005 Jan; 171(1):68-72. PubMed ID: 15477497
[TBL] [Abstract][Full Text] [Related]
49. Serial measurements of lung function in a cohort of young children with bronchopulmonary dysplasia.
Fakhoury KF; Sellers C; Smith EO; Rama JA; Fan LL
Pediatrics; 2010 Jun; 125(6):e1441-7. PubMed ID: 20439591
[TBL] [Abstract][Full Text] [Related]
50. Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD.
Chetty A; Andersson S; Lassus P; Nielsen HC
Pediatr Pulmonol; 2004 Feb; 37(2):128-36. PubMed ID: 14730658
[TBL] [Abstract][Full Text] [Related]
51. Congenital alveolar capillary dysplasia: rare cause of persistent pulmonary hypertension.
Haraida S; Lochbühler H; Heger A; Nerlich A; Diebold J; Wiest I; Müller-Höcker J; Löhrs U
Pediatr Pathol Lab Med; 1997; 17(6):959-75. PubMed ID: 9353836
[TBL] [Abstract][Full Text] [Related]
52. Distribution and number of Clara cells in the normal and disturbed development of the human fetal lung.
Barth PJ; Wolf M; Ramaswamy A
Pediatr Pathol; 1994; 14(4):637-51. PubMed ID: 7971583
[TBL] [Abstract][Full Text] [Related]
53. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease.
Hislop AA; Haworth SG
Pediatr Pulmonol; 1990; 9(3):152-61. PubMed ID: 2148977
[TBL] [Abstract][Full Text] [Related]
54. Assessment of inhibited alveolar-capillary membrane structural development and function in bronchopulmonary dysplasia.
Ahlfeld SK; Conway SJ
Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):168-79. PubMed ID: 24604816
[TBL] [Abstract][Full Text] [Related]
55. Acquired lobar emphysema (overinflation): clinical and pathological evaluation of infants requiring lobectomy.
Azizkhan RG; Grimmer DL; Askin FB; Lacey SR; Merten DF; Wood RE
J Pediatr Surg; 1992 Aug; 27(8):1145-51; discussion 1151-2. PubMed ID: 1403552
[TBL] [Abstract][Full Text] [Related]
56. Risk factors for the degradation of lung elastic fibers in the ventilated neonate. Implications for impaired lung development in bronchopulmonary dysplasia.
Bruce MC; Schuyler M; Martin RJ; Starcher BC; Tomashefski JF; Wedig KE
Am Rev Respir Dis; 1992 Jul; 146(1):204-12. PubMed ID: 1626805
[TBL] [Abstract][Full Text] [Related]
57. Bronchopulmonary Dysplasia and Pulmonary Hypertension. The Role of Smooth Muscle
Raffay TM; Bonilla-Fernandez K; Jafri A; Sopi RB; Smith LA; Cui F; O'Reilly M; Zhang R; Hodges CA; MacFarlane PM; Deutsch G; Martin RJ; Gaston B
Am J Respir Cell Mol Biol; 2021 Jul; 65(1):70-80. PubMed ID: 33780653
[TBL] [Abstract][Full Text] [Related]
58. Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy.
Balinotti JE; Chakr VC; Tiller C; Kimmel R; Coates C; Kisling J; Yu Z; Nguyen J; Tepper RS
Am J Respir Crit Care Med; 2010 May; 181(10):1093-7. PubMed ID: 20133928
[TBL] [Abstract][Full Text] [Related]
59. Cyclooxygenase-2 in human perinatal lung.
Lassus P; Wolff H; Andersson S
Pediatr Res; 2000 May; 47(5):602-5. PubMed ID: 10813584
[TBL] [Abstract][Full Text] [Related]
60. Abnormal pulmonary bombesin immunoreactive cells in Wilson-Mikity syndrome (pulmonary dysmaturity) and bronchopulmonary dysplasia.
Gillan JE; Cutz E
Pediatr Pathol; 1993; 13(2):165-80. PubMed ID: 8464778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
